• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾上腺皮质癌不同亚型的 microRNA 表达模式及其与临床病理的相关性。

MicroRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations.

机构信息

Department of Oncology, University of Turin at San Luigi Hospital, Orbassano, 10043, Torino, Italy.

Department of Clinical & Biological Sciences, University of Turin at San Luigi Hospital, Orbassano, 10043, Torino, Italy.

出版信息

Hum Pathol. 2014 Aug;45(8):1555-62. doi: 10.1016/j.humpath.2014.04.005. Epub 2014 Apr 24.

DOI:10.1016/j.humpath.2014.04.005
PMID:24890943
Abstract

Several microRNAs (miRNAs) were shown to be deregulated in adrenocortical carcinoma (ACC) as compared with adenoma, but a detailed assessment of their expression in its histologic variants and correlation with clinicopathologic characteristics has not been performed, so far. Our aim was to assess the expression of 5 selected miRNAs (IGF2 gene-related miR-483-3p and 5p and hypoxia-induced miR-210, miR-195, and miR-1974) in a series of 51 ACCs (35 classical, 6 myxoid, and 10 oncocytic) as compared with clinical and pathologic features and immunohistochemical expression of prognostic markers, including steroidogenic factor 1, p53, β-catenin, and glucose transporter 1. Oncocytic carcinomas had a reduced expression of miR-483-3p (P = .0325), miR-483-5p (P = .0175), and miR-210 (P = .0366), as compared with other histotypes. Overexpression of miR-210 was associated with the presence of necrosis (P = .0035), high Ki-67 index (P = .0013), and high glucose transporter 1 expression (P = .0043), whereas an inverse correlation with mitotic rate was observed in cases with high miR-493-3p (P = .0191) and miR-1974 (P = .0017) expression. High miR-1974 was also associated with low Ki-67 (P = .0312) and European Network for the Study of Adrenal Tumors stage (P = .0082) and negative p53 (P = .0013). At univariate analysis myxoid/classic histotype (P = .026), high miR-210 (P = .0465), high steroidogenic factor 1 protein (P = .0017), high Ki-67 (P = .0066), and high mitotic index (P = .0006) were significantly associated the shorter overall survival, the latter being the sole independent prognostic factor at multivariate analysis (P = .017). In conclusion, (a) miR-483-3p, miR-483-5p, and miR-210 are differentially expressed in ACC variants, and (b) high miR-210 is associated with clinicopathologic parameters of aggressiveness and a poor prognosis.

摘要

几种 microRNAs(miRNAs)在肾上腺皮质癌(ACC)中与腺瘤相比被证明存在失调,但迄今为止,尚未对其在组织学变异中的表达进行详细评估及其与临床病理特征的相关性。我们的目的是评估 5 种选定的 miRNA(与 IGF2 基因相关的 miR-483-3p 和 5p 以及缺氧诱导的 miR-210、miR-195 和 miR-1974)在 51 例 ACC(35 例经典型、6 例黏液样型和 10 例嗜酸性细胞型)中的表达情况,并与临床病理特征和预后标志物的免疫组织化学表达进行比较,包括类固醇生成因子 1、p53、β-连环蛋白和葡萄糖转运蛋白 1。与其他组织类型相比,嗜酸性细胞瘤中 miR-483-3p(P =.0325)、miR-483-5p(P =.0175)和 miR-210 的表达减少。miR-210 的过表达与坏死的存在有关(P =.0035)、高 Ki-67 指数(P =.0013)和高葡萄糖转运蛋白 1 表达(P =.0043),而在高 miR-493-3p(P =.0191)和 miR-1974(P =.0017)表达的病例中,与有丝分裂率呈负相关。高 miR-1974 也与低 Ki-67(P =.0312)和欧洲肾上腺肿瘤研究网络分期(P =.0082)以及阴性 p53(P =.0013)相关。在单因素分析中,黏液样/经典组织学类型(P =.026)、高 miR-210(P =.0465)、高类固醇生成因子 1 蛋白(P =.0017)、高 Ki-67(P =.0066)和高有丝分裂指数(P =.0006)与总生存率缩短显著相关,后者是多因素分析中的唯一独立预后因素(P =.017)。总之,(a)miR-483-3p、miR-483-5p 和 miR-210 在 ACC 变异体中表达不同,(b)高 miR-210 与侵袭性和预后不良的临床病理参数相关。

相似文献

1
MicroRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations.肾上腺皮质癌不同亚型的 microRNA 表达模式及其与临床病理的相关性。
Hum Pathol. 2014 Aug;45(8):1555-62. doi: 10.1016/j.humpath.2014.04.005. Epub 2014 Apr 24.
2
Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients.血清 miR-483-5p 和 miR-195 可预测肾上腺皮质癌患者的复发风险。
Endocr Relat Cancer. 2013 Jul 5;20(4):579-94. doi: 10.1530/ERC-13-0051. Print 2013 Aug.
3
The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.微小 RNA 失调在肾上腺皮质癌发病机制中的作用。
Endocr Relat Cancer. 2011 Oct 27;18(6):643-55. doi: 10.1530/ERC-11-0082. Print 2011 Oct.
4
Diagnostic and prognostic role of steroidogenic factor 1 in adrenocortical carcinoma: a validation study focusing on clinical and pathologic correlates.类固醇生成因子 1 在肾上腺皮质癌中的诊断和预后作用:一项侧重于临床和病理相关性的验证研究。
Hum Pathol. 2013 May;44(5):822-8. doi: 10.1016/j.humpath.2012.07.025. Epub 2012 Nov 14.
5
Analysis of circulating extracellular vesicle-associated microRNAs in cortisol-producing adrenocortical tumors.分析皮质醇分泌性肾上腺皮质肿瘤中外泌体相关 microRNAs 的循环变化。
Endocrine. 2018 Feb;59(2):280-287. doi: 10.1007/s12020-017-1506-z. Epub 2018 Jan 3.
6
Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis.人类肾上腺皮质肿瘤的整合分子生物信息学研究:微小RNA、组织特异性靶标预测及通路分析
Endocr Relat Cancer. 2009 Sep;16(3):895-906. doi: 10.1677/ERC-09-0096. Epub 2009 Jun 22.
7
High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors.类固醇生成因子-1 在肾上腺肿瘤中的诊断和预后价值很高。
J Clin Endocrinol Metab. 2010 Oct;95(10):E161-71. doi: 10.1210/jc.2010-0653. Epub 2010 Jul 21.
8
Adrenocortical carcinoma: review and update.肾上腺皮质癌:综述与更新
Adv Anat Pathol. 2014 May;21(3):151-9. doi: 10.1097/PAP.0000000000000019.
9
Expression of LIN28 and its regulatory microRNAs in adult adrenocortical cancer.LIN28及其调控性微小RNA在成人肾上腺皮质癌中的表达
Clin Endocrinol (Oxf). 2015 Apr;82(4):481-8. doi: 10.1111/cen.12607. Epub 2014 Nov 3.
10
MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.miR-142-3p 作为食管鳞癌潜在的预后生物标志物。
J Surg Oncol. 2012 Feb;105(2):175-82. doi: 10.1002/jso.22066. Epub 2011 Aug 22.

引用本文的文献

1
Evaluation of microRNAs as liquid biopsy markers in adrenocortical tumors.微小RNA作为肾上腺皮质肿瘤液体活检标志物的评估
Front Endocrinol (Lausanne). 2025 Jan 30;16:1511520. doi: 10.3389/fendo.2025.1511520. eCollection 2025.
2
Updates on WHO 5th edition classification, molecular characteristics and tumor microenvironment of adrenocortical carcinomas.肾上腺皮质癌的世界卫生组织第5版分类、分子特征及肿瘤微环境的最新进展
Endocr J. 2025 Mar 3;72(3):243-257. doi: 10.1507/endocrj.EJ24-0466. Epub 2024 Nov 12.
3
Non-Coding RNAs of Mitochondrial Origin: Roles in Cell Division and Implications in Cancer.
线粒体来源的非编码 RNA:在细胞分裂中的作用及其在癌症中的意义。
Int J Mol Sci. 2024 Jul 8;25(13):7498. doi: 10.3390/ijms25137498.
4
The effect of adjuvant mitotane therapy of the adrenocortical carcinoma on the endometrium and its clinical consequences in menstruating women. Literature review and authors' own experiences.肾上腺皮质癌辅助米托坦治疗对子宫内膜的影响及其在有月经女性中的临床后果。文献综述及作者自身经验。
Am J Cancer Res. 2024 Apr 15;14(4):1802-1814. doi: 10.62347/QKWF9884. eCollection 2024.
5
Advances in translational research of the rare cancer type adrenocortical carcinoma.罕见癌症类型肾上腺皮质癌的转化研究进展。
Nat Rev Cancer. 2023 Dec;23(12):805-824. doi: 10.1038/s41568-023-00623-0. Epub 2023 Oct 19.
6
From diagnosis to resistance: a symphony of miRNAs in pheochromocytoma progression and treatment response.从诊断到耐药:miRNAs 在嗜铬细胞瘤进展和治疗反应中的交响乐。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Apr;397(4):1957-1969. doi: 10.1007/s00210-023-02759-0. Epub 2023 Oct 6.
7
Review of Diagnostic Modalities for Adrenal Incidentaloma.肾上腺偶发瘤的诊断方法综述
J Clin Med. 2023 May 29;12(11):3739. doi: 10.3390/jcm12113739.
8
Exploratory Circular RNA Profiling in Adrenocortical Tumors.肾上腺皮质肿瘤中的环状RNA探索性分析
Cancers (Basel). 2022 Sep 2;14(17):4313. doi: 10.3390/cancers14174313.
9
MicroRNA-149-3p expression correlates with outcomes of adrenocortical tumor patients and affects proliferation and cell cycle progression of H295A adrenocortical cancer cell line.miR-149-3p 的表达与肾上腺皮质肿瘤患者的预后相关,并且影响 H295A 肾上腺皮质癌细胞系的增殖和细胞周期进程。
Hum Cell. 2022 Nov;35(6):1952-1960. doi: 10.1007/s13577-022-00778-2. Epub 2022 Sep 2.
10
MicroRNAs and Long Non-Coding RNAs in Adrenocortical Carcinoma.微小 RNA 和长链非编码 RNA 在肾上腺皮质癌中的作用。
Cells. 2022 Jul 18;11(14):2234. doi: 10.3390/cells11142234.